Smallpox Vaccine Manufacturers See Big Stock Price Increases After Monkeypox Outbreaks Reported

Smallpox Vaccine Manufacturers See Big Stock Price Increases After Monkeypox Outbreaks Reported

On May 26, 2022, U.S. Centers for Disease Control (CDC) officials held a press briefing and announced there had been nine cases of monkeypox identified in seven U.S. states and that two licensed smallpox vaccines were in the national stockpile and ready to be distributed.1 The CDC’s director said, “The U.S. has the resources we […]

Monkeypox Cases in U.S. Coincide With Vaccine Purchases by BARDA

Monkeypox Cases in U.S. Coincide With Vaccine Purchases by BARDA

The World Health Organization (WHO) announced on May 21, 2022 that more than 100 confirmed or suspected cases of monkeypox had been identified in 12 countries, including between one and five confirmed cases in the U.S.1 Most of the cases have occurred in Europe with higher numbers in Portugal, Spain and the U.K.  WHO officials […]

U.S. Taxpayers Paid Billions of Dollars for COVID-19 Vaccine Development

U.S. Taxpayers Paid Billions of Dollars for COVID-19 Vaccine Development

According to the U.S. Centers for Disease Control and Prevention (CDC), the federal government of the United States is providing COVID-19 vaccines free of charge to everyone five years and older living in the United States, regardless of their immigration or health insurance status.1 Although the CDC states that COVID vaccines are provided to the […]

20 Volunteers Suffer Serious Reactions to Johnson & Johnson’s COVID-19 Vaccine

20 Volunteers Suffer Serious Reactions to Johnson & Johnson’s COVID-19 Vaccine

On Sept. 23, 2020, U.S. pharmaceutical and medical devices company Johnson & Johnson, Inc. announced the start of the Phase 3 human clinical trial for its experimental Ad26.COV2.S vaccine for COVID-19. The New Jersey-based company, which is partnering with its subsidiary Janssen Pharmaceutica NV of Belgium on development of the vaccine, is planning to enroll […]

AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event

AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event

News update, Sept. 15, 2020—U.S. regulators paused AstraZeneca’s vaccine trial in the U.S. while the National Institutes of Health (NIH) launches an investigation of its own into a serious side effect in an unnamed patient in Britain. “The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader […]

COVID-19 Vaccine Mandate Unlikely in Canada Say Health Officials

COVID-19 Vaccine Mandate Unlikely in Canada Say Health Officials

The government of Canada has signed deals to purchase COVID-19 vaccines from four pharmaceutical companies when their vaccines are approved to be given to the public. According to Canada’s Minister of Public Services and Procurement Anita Anand, the Canadian government has contracts with Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), Moderna, Novavax and Pfizer […]

Genetically Engineered Cow Plasma Therapy for COVID-19 Will Be Tested on Humans

Genetically Engineered Cow Plasma Therapy for COVID-19 Will Be Tested on Humans

Story Highlights Human trials for a new COVID-19 immunotherapy candidate (SAB-185) that is derived from genetically engineered cow plasma will begin in July 2020. The cows have been genetically engineered to produce human antibodies to fight off COVID-19. Plasma from the cows is expected to assist COVID-19 patients overcome the infection. SAb Biotherapeutics (SAB), a […]

COVID-19 Vaccine Will Likely Be Given Multiple Times, Perhaps Annually

COVID-19 Vaccine Will Likely Be Given Multiple Times, Perhaps Annually

In an interview with the JAMA on June 2, 2020, Anthony Fauci, MD, director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said that while he was “cautiously optimistic” about the effectiveness of the vaccines being developed for COVID-19, he was concerned that any protection the vaccines may provide might only be temporary. […]

GSK and Sanofi COVID-19 Vaccine Produced in Insect Cells with Squalene Adjuvant

GSK and Sanofi COVID-19 Vaccine Produced in Insect Cells with Squalene Adjuvant

Story Highlights GlaxoSmithKline and Sanofi Pasteur are partnering to develop an experimental COVID-19 vaccine. The two global vaccine manufacturers are using existing recombinant DNA vaccine technology and a squalene adjuvant for their COVID-19 vaccine. Clinical trials are scheduled to begin in the second half of 2020 and, if successful, the vaccine will be available in […]

COVID-19 Meltdown and Pharma’s Big Money Win

COVID-19 Meltdown and Pharma’s Big Money Win

Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases (NIAID) told Americans on Apr. 1, 2020 that modeling reports suggested COVID-19 infections could eventually “kill 100,000 to 240,000 Americans,”1 2 3 which was considerably less than the worst case 1.7 million mortality figure the Centers for Disease Control and Prevention (CDC) […]